[关于医疗机构对乙型肝炎病毒感染患者的管理流程的专家共识]
概括
这份专家共识为中国的乙型肝炎病毒 (HBV) 感染管理提供了指导方针. 它的实施旨在提高诊断和治疗率,支持世卫组织2030年消除肝炎的目标.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 传染病管理 传染病管理
背景情况:
- 乙型肝炎病毒 (HBV) 感染仍然是一个重大的公共卫生问题.
- 从例行健康检查中有效利用信息对于HBV管理至关重要.
- 中国医疗机构当前的管理实践需要标准化的指导方针.
研究的目的:
- 在中国医疗机构内就HBV感染患者的管理过程制定专家共识.
- 为预防,诊断和治疗HBV提供标准化指南.
- 为了与世界卫生组织2030年消除肝炎的目标保持一致.
主要方法:
- 召集了临床医学,公共卫生,实验室检测和方法学专家小组.
- 进行了对最新的研究结果和国际HBV预防和治疗指南的全面审查.
- 该共识是考虑到中国医疗和卫生机构的具体情况而制定的.
主要成果:
- 该共识概述了HBV感染患者的标准化管理流程.
- 定义了HBV管理的关键质量控制指标.
- 提供了转诊,诊断和治疗方案的建议.
结论:
- 预计这一专家共识的实施将提高中国病毒性乙型肝炎的诊断和治疗率.
- 标准化管理将有助于有效控制HBV感染.
- 实现世卫组织2030年消除病毒性肝炎作为公共卫生威胁的目标是首要目标.
相关概念视频
Endocarditis III: Medical Management
258
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258
Myocarditis III: Medical Management
216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management
359
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
359
Heart Failure V: Medical Management
319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319
Mitral Stenosis III: Medical Management
301
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
301
Aortic Regurgitation III: Medical Management
443
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
443


